Morgan Stanley’s Moolec Science MLEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5
Closed -$80 8371
2025
Q3
$80 Hold
5
﹤0.01% 7728
2025
Q2
$517 Sell
5
-1
-17% -$111 ﹤0.01% 7444
2025
Q1
$464 Hold
6
﹤0.01% 7380
2024
Q4
$663 Hold
6
﹤0.01% 7316
2024
Q3
$729 Hold
6
﹤0.01% 7268
2024
Q2
$912 Hold
6
﹤0.01% 7165
2024
Q1
$1.14K Sell
6
-5
-45% -$1.39K ﹤0.01% 7154
2023
Q4
$4.08K Buy
11
+5
+83% +$1.95K ﹤0.01% 7039
2023
Q3
$2.32K Hold
6
﹤0.01% 7098
2023
Q2
$3.05K Hold
6
﹤0.01% 7099
2023
Q1
$3.38K Buy
+6
New +$5.38K ﹤0.01% 7144

Other funds holding MLEC

Morgan Stanley's MLEC Position: Q4 2025 in Review

Morgan Stanley sold out of Moolec Science (MLEC) in Q4 2025, closing a stake of 5 shares — an estimated $80 sold.

Morgan Stanley first reported a position in MLEC in Q1 2023 and held it in 11 quarters. The position peaked at $4.08K in Q4 2023. 1 fund tracked by Wall St. Rank holds MLEC as of Q4 2025.

  • Morgan Stanley reported no remaining Moolec Science position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 5 Moolec Science shares in Q4 2025, an estimated $80.
  • Morgan Stanley first reported a position in Moolec Science in Q1 2023 and held it in 11 quarters.
  • Morgan Stanley's Moolec Science position peaked at $4.08K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Moolec Science as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.